Pluristem Therapeutics Inc (PSTI)

[FDApproved]

API Collaboration Signed


I am pleased to announce an additional technology collaboration, this time in the biologics industry. Due to a confidentiality agreement with our partner, I can only share limited details at this stage, and we will provide more information once we are able to do so.We have entered a collaboration agreement with one of the world’s leading manufacturers of specialty biologic APIs for liver and gastroenterological diseases. We believe that proof of concept with this agreement and APIs will open opportunities for us to serve additional API manufacturers in the rapidly growing, multi-billion-dollar biologics market. As part of our collaboration with this major European company, our platform is being utilized to develop and manufacture a unique biologic API used in drugs that treat liver and gastroenterological diseases

https://legacy.pluristem.com/wp-content/uploads/2022/09/Pluri_-_CEO_Letter_FINAL_FOR_RELEASE_isa.pdf